The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer

Menghe Chen, Zitao Liu, Kai Zheng, Chaohua Hu, Pai PengMedicine 2024 · DOI

TL;DR

Triple-negative breast cancer (TNBC) is an aggressive subtype with poor outcomes. This study investigates the roles of Hypoxia-Inducible Factor-1 alpha (HIF-1α) and CD147 in TNBC development, finding that CD147 is upregulated, correlates with poor prognosis, and is closely linked to HIF-1α expression, suggesting it as a potential prognostic biomarker.

What Problem Does This Paper Address?

Triple-negative breast cancer (TNBC) is a particularly challenging form of breast cancer due to its aggressive nature, high recurrence rates, and limited effective treatment options. Unlike other breast cancer subtypes, TNBC lacks expression of estrogen receptors, progesterone receptors, and HER2, making it unresponsive to targeted therapies and hormone treatments. Chemotherapy remains the primary treatment, but TNBC patients often face significant side effects and a higher risk of developing resistance. This necessitates a deeper understanding of the molecular mechanisms driving TNBC development to identify new therapeutic targets and prognostic biomarkers. Specifically, this paper aims to elucidate the roles of HIF-1α, a key player in cellular response to low oxygen, and CD147, a cell surface glycoprotein involved in tumor invasion and metastasis, in the pathogenesis of TNBC.

Methods

The researchers employed a multi-pronged approach to investigate HIF-1α and CD147 in TNBC:

  • Sample Collection: Tissue samples from 84 TNBC patients and 40 patients with breast fibroadenoma (a benign breast condition used as a control) were collected from a hospital pathology department.
  • Prognostic Data: Patient prognosis (disease-free survival - DFS, and overall survival - OS) was gathered through outpatient follow-ups, phone calls, WeChat contacts, and medical records.
  • Protein Expression Analysis:
    • Hematoxylin-Eosin (H&E) Staining: Used for general tissue morphology assessment.
  • Immunohistochemistry (IHC): This technique was crucial for visualizing the location and abundance of HIF-1α and CD147 proteins within the tissue samples.
  • Gene Expression Analysis:
    • Quantitative Real-Time Polymerase Chain Reaction (qPCR): Used to measure the mRNA expression levels of HIF-1α and CD147.
  • Bioinformatics Analysis:
    • Survival Analysis: Kaplan-Meier curves were generated to visualize the relationship between the expression of HIF-1α and CD147 and patient survival outcomes (DFS and OS).
  • Database Mining: The BC-genexminer v4.9 database was utilized to screen a large number of TNBC cases for survival analysis related to HIF-1α and CD147 expression.
  • Statistical Analysis: Standard statistical methods, including chi-squared tests (Fisher's exact test where appropriate), Spearman correlation, and multivariate Cox regression analysis, were used to assess relationships between variables and prognostic significance.

Datasets

  • Patient Cohort: 84 TNBC patients and 40 breast fibroadenoma patients from Xiaogan Central Hospital.
  • Bioinformatics Database: BC-genexminer v4.9, which provided data for survival analysis on 1988 TNBC cases with HIF-1α information and 2022 TNBC cases with CD147 information.

Key Insights and Ideas

  • HIF-1α and CD147 are Upregulated in TNBC: Both HIF-1α and CD147 show significantly higher expression levels in TNBC tissues compared to benign fibroadenoma tissues. This suggests their involvement in the malignant transformation of breast cells.
  • CD147 as a Prognostic Indicator: Unlike HIF-1α, CD147 expression was found to be significantly correlated with poorer patient prognosis (both DFS and OS). This makes CD147 a promising candidate for a prognostic biomarker in TNBC.
  • Interplay Between HIF-1α and CD147: A significant positive correlation was observed between the expression of HIF-1α and CD147. This suggests a potential mechanistic link where one might influence the other, possibly contributing to TNBC development.
  • CD147's Clinical Correlations: CD147 expression was found to be associated with several clinical characteristics, including histological grade, Ki-67 expression, and lymph node metastasis, further underscoring its role in aggressive tumor behavior.

Key Results

  • HIF-1α Expression: Positively expressed in 75% of TNBC samples compared to 27.5% in fibroadenoma. While related to histological grade and lymph node metastasis, it did not show a statistically significant correlation with patient survival (DFS or OS) in this study.
  • CD147 Expression: Positively expressed in 79.8% of TNBC samples compared to 25.0% in fibroadenoma. CD147 expression was significantly correlated with poorer DFS (P < .001) and OS (P < .001).
  • Multivariate Analysis: CD147 was identified as an independent predictor of TNBC prognosis (P < .05), whereas HIF-1α was not.
  • Correlation: A significant positive correlation (r = 0.393, P = .000) was found between HIF-1α and CD147 expression.

Limitations and Future Work

  • Limitations: The authors acknowledge limitations including a relatively small sample size (84 TNBC patients), the study being conducted at a single center, and its retrospective nature. These factors can limit the generalizability of the findings.
  • Future Work: The identified close relationship between CD147 and HIF-1α suggests that CD147 might regulate HIF-1α expression, potentially promoting TNBC development through angiogenesis. Further research is needed to fully elucidate this potential mechanism and explore therapeutic strategies targeting this pathway. The authors suggest that their findings could "initiate novel thought for subsequent mechanism research."

Summary updated

Abstract

CD147 could be a biomarker for the prognosis of TNBC and closely related to the expression of HIF-1α.
BibTeX
@inproceedings{chen2024potential,
  author = {Menghe Chen and Zitao Liu and Kai Zheng and Chaohua Hu and Pai Peng},
  title = {{The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer}},
  booktitle = {Medicine},
  year = {2024},
  doi = {10.1097/md.0000000000038434},
}
Figure